Around five per cent of the adult population, or nearly 250 million people between the ages of 15 and 64, used at least one drug in 2014, according to the latest World Drug Report released today by the United Nations Office on Drugs and...
In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years...
These global International Standards summarize the currently available scientific evidence, describing interventions and policies that have been found to result in positive prevention outcomes and their characteristics. Concurrently, the...
The EDPQS provide a set of principles to help develop and assess the quality of drug prevention. They offer a comprehensive resource outlining all the elements of drug prevention activities. The EDPQS were developed by the European...
The 2016 EU Drug Markets Report — In-depth Analysis is launched at a press conference in Brussels on 5 April by Dimitris Avramopoulos, European Commissioner for Migration, Home Affairs and Citizenship. The Commissioner will be joined by...
